Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.80 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.67 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.67 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.67 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | FAAH | O00519 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | CNR1 | P21554 | 1/20 | 0.57 |
| ▸ | CNR2 | P34972 | 1/20 | 0.57 |
| ▸ | GPR55 | Q9Y2T6 | 2/20 | 0.56 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.54 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.54 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.54 |
| ▸ | PRKCA | P17252 | 1/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15689715 | 0.99 | ALDH1A1 (0.81) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3410263 | 0.99 | ALDH1A1 (0.81) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3409780 | 0.98 | ALDH1A1 (0.83) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3405833 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3403745 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3406019 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL753300 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3410573 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL5053766 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL3406499 | 0.96 | ALDH1A1 (0.76) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090036410-A1 | Structured Phospholipids | BTG INTERNATIONAL LIMITED (GB) | 2009-02-05 | — | — | US | disclosed |
| EP-1885377-A2 | STRUCTURED PHOSPHOLIPIDS FOR TREATING AUTOIMMUNE AND NEURODEGENERATIVE DISEASES | BTG INTERNATIONAL LIMITED (GB) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006056783-A2 | STRUCTURED PHOSPHOLIPIDS FOR TREATING AUTOIMMUNE AND NEURODEGENERATIVE DISEASES | BTG INTERNATIONAL LIMITED (GB) | 2006-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090036410-A1 | Structured Phospholipids | SGMS1, SGMS2, SMPD1 | ALDH1A1 2468/4885SMN1; SMN2 905/4885NR5A2 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.